T/BJACM 001-2023 The Consensus of Combining Traditional Chinese Medicine and Diagnosis for the Symptoms of COVID-19 among Elderly People in Beijing
T/BJACM 001-2023 The Consensus of Combining Traditional Chinese Medicine and Diagnosis for the Symptoms of COVID-19 among Elderly People in Beijing
Basic Information
Scope
Main Technical Content: To improve the treatment outcomes of elderly patients with COVID-19 in Beijing, prevent severe cases, and reduce mortality, based on the characteristics of elderly patients and combined with existing treatment experience, the expert group developed the "Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Elderly Patients with COVID-19" on the basis of the National Version 10 Guidelines. I. Overview of Pathogenesis and Pathophysiology of COVID-19 in the Elderly COVID-19 infection falls under the category of "damp-toxin epidemic" in traditional Chinese medicine. Currently, the main pathogenic factor is the Omicron variant, which exhibits characteristics such as wind, cold, heat, and dryness due to differences in geography, season, individual constitution, and underlying diseases. The pathogen enters through the nose and mouth, primarily affecting the lungs and potentially involving multiple organs including the heart, liver, kidneys, and brain. The disease progression involves key pathogenic mechanisms including dampness, heat, toxin, stasis, and deficiency. II. Treatment Principles for Elderly COVID-19 Patients (1) Treatment Goals: Promote rapid clearance of nucleic acid in elderly COVID-19 patients, alleviate symptoms, prevent severe cases, and reduce mortality. (2) For moderate cases without high-risk factors and stable underlying diseases, follow the National Version 10 and Beijing Version 7 guidelines. (3) For moderate, severe, or critical cases with high-risk factors, unstable underlying diseases, or worsening conditions, refer to this consensus immediately, conduct multidisciplinary consultations, and leverage the advantages of traditional Chinese medicine diagnosis and treatment to tailor individualized strategies, interrupt disease progression, and reduce mortality. (4) For patients over 80 years old, regardless of diagnosis, those exhibiting significant deterioration in mental status, lethargy, reduced